OrthoPediatrics Corp. KIDS R2K

Healthcare · Medical Devices · United States

https://www.orthopediatrics.com

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Market & Price

Market Cap

$441.01M

Current Price

$17.17

High / Low (52W)

$23.68 / $14.64

Beta

0.99

Valuation

Stock P/E

Industry PE

23.65

Forward P/E

PEG Ratio

Book Value

$13.23

Price to Book

1.30

P/S

1.81

EV/EBITDA

-109.63

Dividend Yield

Profitability & Returns

ROCE

-6.27%

ROE

-11.57%

ROA

-3.39%

Profit Margin

-16.31%

Op Margin

-14.04%

EPS (Latest Qtr)

$-0.45

EPS (TTM)

$-1.68

Balance Sheet & Liquidity

Debt/Equity

0.33

Quick Ratio

2.19

Current Ratio

5.21

Debt

$112.20M

Total Assets

$508.63M

Current Assets

$256.42M

Working Capital

$210.22M

Ownership

Promoter Holding

32.63%

Chg in Prom Hold

FII / Inst Holding

66.94%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$504.40M

Total Revenue (TTM)

$243.30M

EBITDA

$-4.60M

Free Cash Flow

$-5.95M

Operating Cash Flow

$-3.98M

Shares Outstanding

25.68M

Gross Margin

73.07%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

24.56%

Profit 5Y

-1,083.89%

Revenue (YoY)

13.30%

Earnings (YoY)

PROS

Compounding revenue at 24.6% over 5 years.

CONS

Earnings shrank at -1083.9% CAGR over 5 years.
Trading 27.5% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	KIDS OrthoPediatrics Corp. R2K	17.17	-	$441.01M	-	-6.27%	-11.57%	24.56%	-1,083.89%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	9.76M	11.80M	12.38M	11.68M	12.09M	15.08M	15.82M	14.57M	14.66M	18.20M	20.74M	18.95M	16.36M	13.59M	22.20M	18.92M	21.46M	26.70M	25.08M	24.81M	23.42M	32.93M	34.95M	31.59M	39.56M	39.97M	44.69M	52.80M	-	-	52.41M	61.08M	61.25M	61.60M	59.36M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14.15M	17.06M	15.98M	16.50M	15.97M
Gross Profit	-	-	7.16M	-	7.42M	8.71M	9.49M	8.83M	8.92M	11.27M	11.98M	10.51M	10.65M	13.62M	15.89M	14.45M	12.21M	10.06M	17.64M	15.12M	16.32M	20.44M	18.55M	18.08M	18.57M	24.98M	25.89M	23.56M	30.02M	30.95M	32.17M	40.80M	-	-	38.26M	44.02M	45.27M	45.11M	43.39M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49.20M	51.70M	50.14M	50.61M	51.73M
Operating Income	-1.49M	-865.00K	-524.00K	-3.25M	-837.00K	-677.00K	-754.00K	-4.20M	-4.39M	-2.12M	-1.17M	-1.87M	-2.72M	-1.79M	-1.54M	-3.03M	-4.50M	-7.02M	-2.50M	-12.74M	-5.97M	-2.85M	-3.64M	-5.56M	-6.39M	-3.74M	-6.96M	-8.59M	-5.59M	-4.51M	-9.72M	-5.67M	-	-	-10.94M	-7.69M	-4.87M	-5.51M	-8.34M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4.29M	-778.00K	-4.78M	1.96M	-3.04M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	404.00K	-	1.13M	1.12M	1.82M	-	2.10M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-10.46M	-7.06M	-11.90M	-9.76M	-10.86M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	196.00K	49.00K	-125.00K	340.00K	-171.00K
Net Income	-1.80M	-288.00K	-846.00K	-3.63M	-1.28M	-1.27M	-1.54M	-4.84M	-5.00M	-2.69M	-1.86M	-2.47M	-3.02M	-2.62M	-2.66M	-5.43M	-4.95M	-9.45M	-4.54M	-14.01M	-10.38M	-3.76M	-2.20M	-	-9.10M	-333.00K	18.54M	-6.81M	-2.89M	-4.59M	-7.80M	-6.03M	-	-	-10.66M	-7.11M	-11.77M	-10.10M	-10.69M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.30	-0.54	-0.24	-0.73	-0.54	-0.19	-0.11	0.00	-0.47	-0.02	0.87	-0.30	-0.13	-0.20	-0.34	-0.26	-	-	-0.46	-0.30	-0.50	-0.43	-0.45
R&D Expense	-	-	501.00K	-	687.00K	668.00K	1.13M	-	1.22M	1.11M	1.12M	-	1.21M	1.23M	1.40M	-	1.26M	881.00K	1.08M	-	1.31M	1.32M	1.30M	-	2.03M	1.75M	2.21M	2.45M	2.97M	2.56M	3.00M	2.54M	2.58M	-	2.35M	2.16M	2.33M	-	2.23M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	37.30M	45.62M	57.56M	72.55M	71.08M	-	122.29M	148.73M	204.73M	236.35M
Cost of Revenue	-	-	-	-	-	-	-	31.63M	37.48M	56.13M	63.69M
Gross Profit	21.64M	26.37M	34.45M	42.68M	54.62M	55.03M	-	90.66M	111.25M	148.60M	172.66M
Operating Expenses	-	-	-	-	-	-	-	112.45M	137.02M	178.12M	201.66M
Operating Income	-6.59M	-6.13M	-6.47M	-9.55M	-9.08M	-26.75M	-	-21.79M	-25.77M	-29.52M	-29.00M
EBITDA	-	-	-	-	-	-	-	-8.69M	-8.38M	-10.44M	-7.88M
Interest Expense	-	-	-	-	-	-	2.25M	2.42M	-	-	-
Pretax Income	-	-	-	-	-	-	-	-3.69M	-21.31M	-41.93M	-39.19M
Tax Provision	-	-	-	-	-	-	-	-4.95M	-338.00K	-4.11M	460.00K
Net Income	-7.89M	-6.57M	-8.93M	-12.03M	-13.73M	-32.94M	-	1.26M	-20.97M	-37.82M	-39.65M
Diluted EPS	-	-	-	-	-0.94	-1.82	-	0.06	-0.92	-1.64	-1.69
R&D Expense	1.79M	2.22M	3.42M	4.73M	5.75M	5.27M	5.54M	8.45M	10.89M	11.03M	9.10M

Compounded Sales Growth

5 Years:	24.56%
1 Year:	13.30%

Compounded Profit Growth

5 Years:	-1,083.89%
1 Year:	-

Stock Price Performance

1 Year:	-13.98%
6 Months:	-10.06%
3 Months:	-10.43%
1 Month:	+17.28%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	30.68M	82.30M	112.11M	182.15M	320.41M	-	427.73M	438.75M	473.21M	508.63M
Current Assets	-	-	-	-	-	-	-	-	226.72M	226.50M	237.17M	256.42M
Cash & Equivalents	6.58M	3.88M	1.61M	42.58M	60.69M	70.78M	28.76M	-	8.99M	31.05M	43.82M	19.56M
Inventory	-	-	-	-	-	-	-	-	78.19M	105.85M	117.00M	133.79M
Receivables	-	-	-	-	-	-	-	-	24.80M	34.62M	42.36M	53.84M
Total Liabilities	-	-	24.68M	34.81M	30.37M	39.79M	85.64M	-	49.08M	61.72M	118.64M	162.03M
Current Liabilities	-	-	7.25M	9.47M	9.22M	13.66M	35.03M	-	30.87M	41.67M	33.96M	46.20M
Long Term Debt	-	-	17.43M	25.34M	21.16M	26.07M	1.04M	-	763.00K	9.91M	72.96M	99.82M
Total Debt	-	-	-	-	-	-	-	-	907.00K	10.06M	73.12M	99.99M
Total Equity	-42.65M	-54.11M	-65.31M	47.49M	81.73M	142.36M	234.77M	-	378.65M	377.02M	354.57M	346.60M
Shares Outstanding	-	-	-	-	-	-	-	-	22.88M	23.38M	24.22M	25.09M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-892.00K	-1.12M	-7.22M	-15.58M	-17.77M	-18.53M	-	-21.77M	-27.05M	-27.05M	-4.85M
Investing Cash Flow	-1.71M	-4.75M	-6.54M	-5.96M	-61.92M	-69.69M	-	-113.37M	41.68M	-13.16M	-43.63M
Financing Cash Flow	-98.00K	3.60M	54.73M	39.66M	91.02M	46.73M	-	135.97M	7.30M	53.13M	23.98M
Capital Expenditure	-2.21M	-4.35M	-5.21M	-5.25M	-11.82M	-10.50M	-	-10.03M	-16.88M	-14.26M	-11.11M
Free Cash Flow	-3.10M	-5.47M	-12.42M	-20.84M	-29.59M	-29.03M	-	-31.80M	-43.92M	-41.31M	-15.96M
Net Change in Cash	-	-	-	-	-	-	-	837.00K	21.93M	12.93M	-24.50M
Dividends Paid	0	0	5.96M	0	0	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	70.7%	75.5%	74.2%	75.3%	77.4%	-	74.1%	74.8%	72.6%	73.1%
Operating Margin %	-	-16.4%	-14.2%	-16.6%	-12.5%	-37.6%	-	-17.8%	-17.3%	-14.4%	-12.3%
Net Margin %	-	-17.6%	-19.6%	-20.9%	-18.9%	-46.3%	-	1.0%	-14.1%	-18.5%	-16.8%
ROE %	14.6%	10.1%	-18.8%	-14.7%	-9.6%	-14.0%	-	0.3%	-5.6%	-10.7%	-11.4%
ROCE %	-	-26.2%	-8.9%	-9.3%	-5.4%	-9.4%	-	-5.5%	-6.5%	-6.7%	-6.3%

Shareholding Pattern

Insiders

32.63%

Institutions

66.94%

Public Float

99.36%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Brown Advisory Inc.	5.91%	1.52M	$26.06M
2	Millennium Management Llc	4.82%	1.24M	$21.24M
3	Blackrock Inc.	4.57%	1.17M	$20.16M
4	Morgan Stanley	4.44%	1.14M	$19.59M
5	Braidwell LP	4.28%	1.10M	$18.89M
6	Granahan Investment Management LLC	3.49%	896.74K	$15.40M
7	Wellington Management Group, LLP	3.46%	887.44K	$15.24M
8	Vanguard Capital Management LLC	2.80%	718.18K	$12.33M
9	Soleus Capital Management, L.P.	2.40%	615.45K	$10.57M
10	Dimensional Fund Advisors LP	2.13%	546.63K	$9.39M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for KIDS

VentureBeat AI Fri, 16 Jan 2026

Listen Labs raises $69M after viral billboard hiring stunt to scale AI customer interviews

<p>Alfred Wahlforss was running out of options. His startup, <a href="https://listenlabs.ai/">Listen Labs</a>, needed to hire over 100 engineers, but competing against Mark Zuckerberg's <a href="…

CNBC Top News Sun, 31 May 2026

I've studied over 200 kids—the ones with high emotional intelligence do 7 things

Reem Raouda is a certified conscious parenting coach whose philosophy centers around emotional safety. After studying over 200 kids, she shares the key signs of emotionally intelligent kids.

KIDS · Healthcare